Valion Bio (VBIO) Current Leases (2021 - 2026)

Valion Bio has reported Current Leases for 5 years, with the latest figure at $533000.0 in Q2 2026.

• On a quarterly basis, Current Leases changed N/A year-over-year to $533000.0 in Q2 2026; TTM through Jun 2026 was $533000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $193000.0, up 18.4% from the prior year.
• Current Leases was $533000.0 for Q2 2026 at Valion Bio, up from $180000.0 in the prior quarter.
• The five-year high for Current Leases was $533000.0 in Q2 2026, with the low at $160000.0 in Q3 2022.
• Average Current Leases over 4 years is $210700.0, with a median of $176500.0 recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Current Leases grew 18.4% in 2023, then slipped 1.1% in 2024.
• Over 4 years, Current Leases stood at $163000.0 in 2022, then climbed by 18.4% to $193000.0 in 2023, then declined by 6.74% to $180000.0 in 2024, then soared by 196.11% to $533000.0 in 2026.
• The last three Current Leases figures came in at $533000.0 (Q2 2026), $180000.0 (Q1 2024), and $193000.0 (Q4 2023), per Business Quant data.